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Abstract. The hybridisation of genetic algorithm (GAs) and artificial
neural network (ANNs) are not new for microarray studies. However,
these hybrid systems require data preprocessing and focus on classifi-
cation accuracy. In this paper, a feature selection method based on the
hybridisation of GAs and ANNs for oligonucleotide microarray data is
proposed. The fitness values of the GA chromosomes are defined as the
number of correctly labelled samples returned by the ANN. For gene val-
idation, three supervised classifiers have been employed to evaluate the
significance of selected genes based on a separate set of unknown sam-
ple data. Experimental results show that our method is able to extract
informative genes without data preprocessing and this has reduced the
gene variability errors in the selection process.
1 Introduction
The main challenge when working with microarray data is to identify compu-
tationally effective and biologically meaningful analysis models that extract the
most informative and unbiased marker genes from a large pool of genes that
are not involved in the array experiments. Numerous genetic algorithm (GA)
and neural network (ANN) hybrid systems have been developed to emphasize
effective classification [1–3, 8, 11]. Beiko and Charlebois [1] utilised the evolu-
tionary ability of GAs to identify the best combinations of sequence indices and
ANN architecture for DNA sequence classification. Meanwhile, Karzynski et al.
[8] used GAs to optimise both the architecture and weight assignment of ANNs
for multiclass recognition. In addition to optimising ANNs using GAs, recent
studies tend to utilise the universal computational power of ANNs to compute
GA fitness function for cancer classification. For instance, Bevilacqua et al. [2]
and Lin et al. [11] applied the error rates returned by ANN to determine the
fitness of GA chromosome in the classification of breast cancer metastasis recur-
rence and multiclass microarray datasets, respectively. Cho et al. [3] defined GA
fitness based on ANN classification results on SRBCTs tumour data.
Instead of improving classification performance, our work is focused on fea-
ture selection for oligonucleotide microarray data using GAs and ANNs. For gene
selection, the fitness values of GA chromosomes are defined as the number of
correctly labelled samples returned by a feedforward ANN. To show the selec-
tion performance, the same experimental dataset as Golub et al. [7] is used. For
gene validation, some commonly applied classifiers, such as multilayer percep-
tron (MLP), support vector machine (SVM) and nearest neighbour (KNN) have
been employed using the WEKA suite of data mining software and the selection
results are compared with previous experiments based on the same experimental
dataset.
The rest of the paper is organised as follows. Section 2 describes proposed fea-
ture selection model. The experiment results are presented in Section 3. Finally
in Section 4, the conclusion is drawn.
2 Methods
2.1 Feature Selection Model
The proposed model has three components: population initialisation, fitness com-
putation and pattern evaluation.
Population initialisation A set of features from the experimental dataset is
randomly chosen by the GA. These features form a finite feature space and are
used as a basis for the fitness computation of each member of the population.
To find the optimal population size, preliminary experiments were conducted on
4 variants of population sizes: 50, 100, 200 and 300. The population size of 300
was found to be the most optimal. Each chromosome is represented by 10 genes
expressions which is encoded with a real number representation.
Fitness computation The fitness function is the number of correctly labelled
samples returned by the ANN as shown in equation Eq. 1. For proposed method,
chromosomes with higher fitness values are more likely to survive than those with
least values.
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where sik, tik, aik, oik and ck represent sample data, target value of the
sample, network activation output, actual output value and class centroid value,
respectively. A feedforward ANN with the structure of 10-5-2 and network size
of 67 including 5 and 2 bias nodes in the hidden and output layers, respectively,
is constructed. The tanh activation function is employed as it is one of the
commonly used nonlinear functions in the ANN.
Pattern evaluation Two sets of evaluation were performed using the GA:
feature evaluation and network evaluation. For feature evaluation, two parent
chromosomes are crossovered to produce a new offspring which is then mutated
to create diversity from its parent. For network evaluation, two parent networks
are crossovered to form a new set of network weights which then will be used
to compute the fitness value of feature offspring. To retain the best chromo-
some set in each generation, an elitism scheme was applied in which only 1
chromosome will be replaced in each generation. For genetic operations, binary
tournament selection, single-point crossover and simple mutation are used. The
rates of crossover and mutation are 0.5 and 0.1, respectively.
Termination criteria Two termination criteria are defined: criteria (A) is used
to stop the entire selection process and criteria (B) is used to stop the fitness
evaluation. Both criteria (A) and (B) were set to 5000 and 20000 repetitions,
respectively.
2.2 Data Acquisition
For performance evaluation, the acute leukaemia dataset [7] which contains acute
lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML) tumour
data are considered. There are 72 samples and 7129 gene expression levels in
the dataset. Among 72 sample data, 38 samples (27 ALL, 11 AML) are used
for gene selection and the remaining 34 samples (20 ALL, 14 AML) are used for
validating the significance of the selected gene subsets. To assess the efficacy of
the proposed method, the data normalisation process is ignored.
2.3 Classification
In order to validate the significance of the selected genes, 3 supervised clas-
sifiers: MLP, SMO and IBk; are employed using WEKA suite of data mining
(http://www.cs.waikato.ac.nz/ml/weka/). The MLP is a 3-layered backpropa-
gation perceptron-based model that employs a sigmoid activation function; the
SMO is an implementation of support vector machines (SVMs) that compute
the upper bound of support vector weights using a sequential minimal optimi-
sation algorithm; the IBk is an implementation of a k-nearest neighbour (KNN)
classifier that employs the similarity distance metric in forming neighbours. All
classifiers are implemented with the default settings except for the IBk algorithm
where k is set to 3.
3 Results and Discussions
3.1 Gene Selection Results
By repeating the selection process 5000 times using the training set, the top 48
genes based on the selection frequency of at least 50 selections and above are
ranked. Table 1 shows the comparison of the selected genes from our method and
previous works on the experiment dataset. Out of the 48 selected genes, 28 are
consistent with Golub et al. [7]. The significant genes such as CST3 (M27891),
zyxin (X95735), c-myb (U22376), adipsin (M84526), CCND3 (M92287), mac-
marcks (HG1612-HT1612), proteasome IOTA chain (X59417), IL 8 (M28130),
azurocidin (M96326) and IL 8 precursor (Y00787) are highly ranked by our
method. Amongst these genes, CST3 and zyxin genes have been reported as the
strongest predictors in related literature [4, 5, 7, 10, 12].
3.2 Classification Results
As previously described, 34 out of 72 samples are used to assess the significance
of the selected genes based on the 3 supervised classifiers. Table 2 shows the clas-
sification results based on varying number of selected genes. 33/34 test samples
have been correctly classified with an accuracy of 97.06% when there are at least
8 selected genes. The classification performance is reduced when there are less
than 8 genes used for class discrimination. Although genes M27891 and X95735
have been identified as the 2 strongest predictors in literature, however, the clas-
sification performance based on these combined genes are 91.18%, 85.29% and
91.18% for MLP, SMO and IBk, respectively. By increasing the number of se-
lected genes for classification, the performance has been improved. This confirms
that there are many strong predictors that can be used for classification and this
supports the similar observations on works [7, 10].
3.3 Related Works
Table 3 shows some related research on the microarray experiment dataset. Sev-
eral selection techniques have been applied to find the optimal set of genes,
including signal-to noise (S2N), Pearson correlations, correspondence analysis
(COA), principal component analysis (PCA), between-group/within-group ra-
tio (BSS/WSS) and recursive feature elimination (RFE). Some produce small
amount of genes in the selection process and some require more genes for better
search performance. However, all existing selection methods based on oligonu-
cleotide microarray data require data preprocessing for optimal search. Depend-
ing on the selection approach and classification method, varying data preprocess-
ing techniques are implemented. This has contributes to the genes variability on
selection results. Our method, on the other hand, has the ability to extract in-
formative genes without data preprocessing which reduces variation errors on
the selected genes.
4 Conclusions
In this paper, a feature selection method based on genetic algorithms and neural
networks for oligonucleotide microarray data was developed. For the selection
process, the fitness value of the selected gene subset is based on the correctly
Table 1. Comparison of top-48 selected genes by proposed method and previous works.
The gene selection is based on the selection frequency of 50 times or more. Genes in
Italic had been reported by Golub et al. [7].
Rank Index Acc No Description Marker
Genes
1 1882 M27891 CST3 Cystatin C abcd
2 4847 X95735 Zyxin acd
3 5772 U22376 C-myb gene abc
4 2288 M84526 Adipsin ad
5 2354 M92287 CCND3 Cyclin D3 ab
6 804 HG1612-
HT1612
Macmarcks
7 4328 X59417 Proteasome IOTA chain ab
8 6200 M28130 Interleukin 8 (IL8) gene abd
9 2402 M96326 Azurocidin gene abd
10 6201 Y00787 Interleukin 8 precursor abd
11 2121 M63138 CTSD Cathepsin D a
12 1120 J04615 SNRPN Small nuclear ribonucleoprotein polypeptide N
13 5552 L06797 Probable G protein-coupled receptor LCR1 homolog b
14 5501 Z15115 TOP2B Topoisomerase (DNA) II beta b
15 1704 M13792 ADA Adenosine deaminase b
16 6041 L09209 APLP2 Amyloid beta (A4) precursor-like protein 2
17 4211 X51521 VIL2 Villin 2
18 1928 M31303 Oncoprotein 18 (Op18) gene a
19 4373 X62320 GRN Granulin
20 1745 M16038 LYN V-yes-1 Yamaguchi sarcoma viral related oncogene
homolog
ac
21 2642 U05259 MB-1 gene bd
22 6218 M27783 ELA2 Elastatse 2, neutrophil cd
23 760 D88422 Cystatin A cd
24 4377 X62654 ME491 gene for Me491/CD63 antigen
25 6539 X85116 Epb72 gene exon 1 a
26 3320 U50136 Leukotriene C4 synthase (LTC4S) gene ac
27 1685 M11722 Terminal transferase mRNA bd
28 4535 X74262 Retinoblastoma binding protein P48
29 5039 Y12670 LEPR Leptin receptor ac
30 5191 Z69881 Adenosine triphosphatase, calcium
31 1779 M19507 MPO Myeloperoxidase bd
32 4052 X04085 Catalase (EC 1.11.1.6) 5’flank and exon 1 mapping to
chromosome 11, band p13 (and joined CDS)
33 1829 M22960 PPGB Protective protein for beta-galactosidase (galac-
tosialidosis)
34 6378 M83667 NF-IL6-beta protein mRNA d
35 3258 U46751 Phosphotyrosine independent ligand p62 for the Lck SH2
domain mRNA
a
36 1133 J04990 Cathepsin G precursor b
37 2020 M55150 FAH Fumarylacetoacetate ac
38 6376 M83652 PFC Properdin P factor, complement d
39 5954 Y00339 CA2 Carbonic anhydrase II
40 6277 M30703 Amphiregulin (AR) gene
41 6308 M57731 GRO2 oncogene d
42 312 D26308 NADPH-flavin reductase
43 1249 L08246 Induced myeloid leukemia cell differentiation protein
MCL1
a
44 6855 M31523 TCF3 Transcription factor 3
45 3056 U32944 Cytoplasmic dynein light chain 1 (hdlc1) mRNA
46 878 HG2855-
HT2995
Heat Shock Protein, 70 Kda (Gb:Y00371)
47 1630 L47738 Inducible protein mRNA
48 1962 M33680 26-kDa cell surface protein TAPA-1 mRNA b
a represents marker genes reported by Cho and Won [4]
b represents marker genes reported by Culhane et al. [5]
c represents marker genes reported by Li and Yang [10]
d represents marker genes reported by Mao et al. [12]
Table 2. Classification performance comparison based on the number of genes used in
the test set.
Number of genes MLP SMO IBk (k=3)
top 2 91.18 85.29 91.18
top 4 94.12 97.06 94.12
top 8 97.06 97.06 97.06
top 16 97.06 97.06 97.06
top 32 97.06 97.06 97.06
top 48 97.06 97.06 97.06
Table 3. Some relevant works on acute leukaemia.
Authors Selection
method
Classification
method
Data preprocessing step Marker
genes
identified
Proposed method GANN - - 48
Golub et al. [7] S2N WV mean and deviation normal-
isation
50
Cho and Won [4] Pearson ensemble MLPs max-min normalisation 50
Culhane et al. [5] COA, PCA BGA for COA: negative values
transformation; for PCA:
mean and deviation normal-
isation
50
Li and Yang [10] stepwise
selection
logistic regression log transformation 12
Dudoit et al. [6] BSS/WSS various discriminant
methods
thresholding, filtering, log
transformation, mean and
variance normalisation
-
Mao et al. [12] RFE, F-test SVMs preprocessing step used in
[6]
20
Lee and Lee [9] BSS/WSS SVMs preprocessing step used in
[6]
20
labelled sample data computed by neural networks. For performance evaluation,
the selected genes have been evaluated by implementing commonly used classi-
fiers based on a separate set of unknown sample data. The experimental results
show that our method is able to identify a set of informative genes without data
preprocessing this has reduced the potential of gene variability problems.
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